Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

[Weekend Money] After Dominating Domestic Hospital Rooms, This Company Races ...

26 July 2026 · By · Wire by Fusion42

Published

26 July 2026

Topic

opportunities

◆ Sectors

Digital Health

◆ Geography

South Korea

◆ Source

Read at asiae.co.kr →

◆ Verified

Fusion42 · 26 July 2026 · Fusion42 review

Seers, a South Korean digital healthcare company, is scaling its hospital ward monitoring platform 'thynC' and ECG analysis service globally after dominating the domestic market, with FDA clearance and Middle East contracts now opening US and international expansion.

This Wire brief sits within Fusion42's coverage of Digital Health.

◆ ◆ The Wire takeaway

If you're building hospital monitoring or remote patient management in Asia or the US, Seers just proved the model scales and clears FDA. They've moved from domestic recurring revenue to US market entry—watch their customer acquisition strategy there, because their next hire will be your competitor or your acquirer.

◆ Coverage

1 source · 26 Jul 2026

◆ Related on Wire

◆ Topics

Digital Healthhospital-monitoringmedical-aiglobal-expansionrecurring-revenuefda-clearance